Literature DB >> 22052761

Active surveillance for prostate cancer: a review.

Laurence Klotz1.   

Abstract

Active surveillance is a solution to the widely acknowledged problem of overdiagnosis and overtreatment of clinically insignificant disease which accompanies early detection of prostate cancer using PSA and biopsy. It is an approach to the management of favorable risk prostate cancer which uses the opportunity provided by the long natural history of the disease to incorporate a period of initial observation into patient management. In this review article, the rationale, criteria for patient selection, method of follow up, trigger for intervention, and results of active surveillance are reviewed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052761

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  5 in total

1.  Temporal changes in the pathologic assessment of prostate cancer.

Authors:  M Scott Lucia; Adrie van Bokhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

2.  MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.

Authors:  Fajun Qu; Xingang Cui; Yi Hong; Junkai Wang; Yao Li; Lu Chen; Yushan Liu; Yi Gao; Danfeng Xu; Quanxing Wang
Journal:  Mol Cell Biochem       Date:  2013-02-17       Impact factor: 3.396

3.  Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

Authors:  Dimo Dietrich; Oliver Hasinger; Lionel L Bañez; Leon Sun; Geert J van Leenders; Thomas M Wheeler; Chris H Bangma; Nicolas Wernert; Sven Perner; Stephen J Freedland; John M Corman; Michael M Ittmann; Amy L Lark; John F Madden; Arndt Hartmann; Philipp Schatz; Glen Kristiansen
Journal:  J Mol Diagn       Date:  2012-12-22       Impact factor: 5.568

Review 4.  Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.

Authors:  Abraham Morgentaler; William P Conners
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

5.  Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.

Authors:  Matteo Ferro; Giuseppe Lucarelli; Dario Bruzzese; Giuseppe Di Lorenzo; Sisto Perdonà; Riccardo Autorino; Francesco Cantiello; Roberto La Rocca; Gian Maria Busetto; Amelia Cimmino; Carlo Buonerba; Michele Battaglia; Rocco Damiano; Ottavio De Cobelli; Vincenzo Mirone; Daniela Terracciano
Journal:  Oncotarget       Date:  2017-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.